More about Eris Lifesciences Limited
Fundamentals for Eris Lifesciences Limited
Regulatory Filings for Eris Lifesciences Limited
Tier 2 Towns Are Outsaving India's Big Metros
The Renewable Success Story Beyond Solar
Startups Mint India’s New Billionaires
India's Biggest IPO Has a Bigger Meaning
Technicals for Eris Lifesciences Limited
Price Summary
On 2026-07-01, Eris Lifesciences Limited's shares started at 1448.4, peaked at 1458.0, bottomed out at 1420.0, and ended -0.14% down at 1446.4, with 61346 shares traded.Over the past year, the stock's highest price was 1816.6, and its lowest was 1271.0.
Technicals
Support and Resistance: The price currently sits at 1446.4, finding support at 1441.2 and resistance at 1534.4. These levels define a range for Eris Lifesciences Limited where the price may move, with 1441.2 offering a base and 1534.4 limiting upward momentum.Aroon: The AROON is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
Parabolic SAR: The PSAR maintains a bearish stance, establishing a resistance level that could act as a barrier to any upward trends. This ongoing bearish outlook suggests that the market may continue to face resistance, keeping prices in check.
Stochastic: The STOCHASTIC is showing a neutral stance, not indicating a clear upward or downward trend for Eris Lifesciences Limited. This suggests a period of market balance, where neither side is showing dominance.
Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages suggests a bearish trend, but the wavering slopes of the 20 and 50 SMAs hint at a potential shift. This weakening of momentum could indicate that the bearish trend is running out of steam, possibly leading to a bullish reversal in the near future. Investors should be aware of the possibility of a market turnaround as the current downtrend weakens for Eris Lifesciences Limited.
The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Watches to Wealth: Titan's New Empire
SEBI's New Gateway Is Rewiring Foreign Investment in India
Why Japan Backs India’s Truckers